U.S. Urges India To Impose Strict Laws Against Counterfeit Drugs
This article was originally published in PharmAsia News
Executive SummaryMUMBAI - The Office of the United States Trade Representative has taken a strong stand against counterfeit drugs in India, placing the country on the USTR priority watch list and calling for better and effective systems to check counterfeit drugs
You may also be interested in...
Some lawyers say views on India’s patent laws may be softening despite India winding up again on the U.S. Priority Watch List.